These outcomes, along with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two support the thought of targeting ACKR3 as a novel technique to modulate the opioid process, which could open new therapeutic avenues for opioid-related Diseases.Importantly, these receptors ended up uncover